According to SNS Insider, the global spinal muscular atrophy (SMA) treatment market, valued at USD 4.48 billion in 2023, is projected to reach USD 7.65 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.9% over the forecast period from 2024 to 2031.
The SMA Treatment Market is set to grow from USD 4.48 billion in 2023 to USD 7.65 billion by 2031, reflecting a CAGR...